GD-HKGBA Holdings (01396) plans to issue a total of 20.311 million subscription shares at a discount of approximately 8.40%, raising approximately HK$121.6 million.
Guangdong-Hong Kong Bay Holdings (01396) announced that on February 3, 2026, the company entered into a subscription agreement with the subscriber. According to the agreement, the company has conditionally agreed to issue and issue, and the subscriber has conditionally agreed to subscribe for a total of 20.311 million subscription shares, representing approximately 1.78% of the total issued share capital of the company as of the date of this announcement; and approximately 1.74% of the total issued share capital of the company after the issuance and subscription of the subscription shares (assuming that there will be no other changes in the issued share capital of the company from the date of this announcement to the completion of the subscription). The subscription price for each subscription share is HK$6.00, which represents a discount of approximately 8.40% compared to the closing price of HK$6.55 per share reported by the Stock Exchange on the date of the subscription agreement.
GD-HKGBA HLDGS (01396) announced on February 3, 2026, that the company has entered into a subscription agreement with subscribers. According to this agreement, the company has conditionally agreed to issue and issue, while the subscribers have conditionally agreed to subscribe for a total of 20.311 million subscription shares, accounting for approximately 1.78% of the company's total issued share capital as of the date of this announcement; and approximately 1.74% of the total issued share capital after the issuance and subscription of the subscription shares (assuming that there will be no other changes to the company's issued share capital from the date of this announcement to the completion of the subscription).
The subscription price for each subscription share is HK$6.00, which is at a discount of approximately 8.40% compared to the stock price of HK$6.55 per share reported by the Stock Exchange on the date of the subscription agreement.
The total amount of funds raised from the subscription is expected to be approximately HK$121.9 million, while the net proceeds are expected to be approximately HK$121.6 million (after deducting the expenses of the subscription), equivalent to a net issue price of approximately HK$5.99 per subscription share. The Board of Directors intends to use the net proceeds from the subscription for the group's general operating funds, with approximately 90% intended for potential AI computing power cloud service projects; and approximately 10% intended for daily operating expenses.
Related Articles
.png)
"K drug" and new drugs drive Merck & Co., Inc. (MRK.US) Q4 performance exceeded expectations, but the HPV vaccine dilemma dragged down growth prospects.

HAIER SMARTHOME (06690) spent 88,700 euros on February 2 to repurchase 43,600 shares.

UNIVERSE ENT (01046) issued a profit warning, expecting to incur a mid-term loss of approximately HK$7 million to HK$17 million.
"K drug" and new drugs drive Merck & Co., Inc. (MRK.US) Q4 performance exceeded expectations, but the HPV vaccine dilemma dragged down growth prospects.
.png)
HAIER SMARTHOME (06690) spent 88,700 euros on February 2 to repurchase 43,600 shares.

UNIVERSE ENT (01046) issued a profit warning, expecting to incur a mid-term loss of approximately HK$7 million to HK$17 million.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


